SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-08-001881
Filing Date
2008-05-09
Accepted
2008-05-09 16:13:25
Documents
4
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q w57780e10vq.htm 10-Q 624552
2 EXHIBIT 31.1 w57780exv31w1.htm EX-31.1 8422
3 EXHIBIT 31.2 w57780exv31w2.htm EX-31.2 8412
4 EXHIBIT 32.1 w57780exv32w1.htm EX-32.1 4711
  Complete submission text file 0000950133-08-001881.txt   647544
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51863 | Film No.: 08818599
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1